Who invested in LigoCyte Pharmaceuticals?
LigoCyte Pharmaceuticals's investors include Novartis Venture Fund, MedImmune Ventures, Forward Ventures and Athenian Venture Partners.
United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$72Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Jun 2012
No investor was named in the report.
Reported by sec.govSEC filing: $5.5M sold, first sale Jun 2011
No investor was named in the report.
Reported by sec.govSEC filing: $6.5M sold, first sale Apr 2010
From a historical funding recordSEC filing: $29M sold, first sale Mar 2008
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
LigoCyte Pharmaceuticals's investors include Novartis Venture Fund, MedImmune Ventures, Forward Ventures and Athenian Venture Partners.
LigoCyte Pharmaceuticals has raised $72M across 5 rounds since 2008.
LigoCyte Pharmaceuticals's most recent round was a Venture of $2.0M in Jun 2012.
LigoCyte Pharmaceuticals's largest round on record is $29M (Series C), in Aug 2009.
LigoCyte Pharmaceuticals's first round on record, in Apr 2008, was backed by Novartis Venture Fund, MedImmune Ventures and Forward Ventures and 1 others.
LigoCyte Pharmaceuticals's latest named round is a Venture, in Jun 2012.
LigoCyte Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.